Blue Trust Inc. raised its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 58,723 shares of the company’s stock after purchasing an additional 569 shares during the period. Blue Trust Inc.’s holdings in Procter & Gamble were worth $9,528,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. HighPoint Advisor Group LLC purchased a new position in shares of Procter & Gamble in the fourth quarter valued at about $17,696,000. Dfpg Investments LLC lifted its position in shares of Procter & Gamble by 1.7% in the fourth quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock worth $3,680,000 after buying an additional 424 shares in the last quarter. Campbell Wealth Management lifted its position in shares of Procter & Gamble by 13.1% in the fourth quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock worth $291,000 after buying an additional 231 shares in the last quarter. Herold Advisors Inc. lifted its position in shares of Procter & Gamble by 2.2% in the fourth quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock worth $3,897,000 after buying an additional 581 shares in the last quarter. Finally, V Square Quantitative Management LLC lifted its position in shares of Procter & Gamble by 29.0% in the first quarter. V Square Quantitative Management LLC now owns 43,202 shares of the company’s stock worth $7,010,000 after buying an additional 9,716 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
PG stock traded up $1.38 during midday trading on Friday, reaching $165.21. The stock had a trading volume of 6,509,248 shares, compared to its average volume of 5,655,382. The stock has a market cap of $389.92 billion, a PE ratio of 27.00, a P/E/G ratio of 3.13 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The firm has a fifty day simple moving average of $165.82 and a two-hundred day simple moving average of $159.35. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $169.41.
Procter & Gamble Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were given a dividend of $1.0065 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a yield of 2.44%. The ex-dividend date was Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.85%.
Insiders Place Their Bets
In other news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the sale, the insider now directly owns 11,507 shares in the company, valued at approximately $1,858,265.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the sale, the insider now directly owns 11,507 shares in the company, valued at approximately $1,858,265.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 855 shares of the firm’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the sale, the chief executive officer now owns 4,004 shares in the company, valued at $634,634. The disclosure for this sale can be found here. In the last three months, insiders have sold 154,544 shares of company stock valued at $25,413,051. Company insiders own 0.17% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on PG shares. StockNews.com upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Tuesday, June 25th. BNP Paribas started coverage on Procter & Gamble in a research report on Monday, June 24th. They set an “outperform” rating and a $187.00 price objective on the stock. Barclays upped their price objective on Procter & Gamble from $168.00 to $170.00 and gave the company an “overweight” rating in a research report on Tuesday, April 23rd. Deutsche Bank Aktiengesellschaft decreased their price objective on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. Finally, Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and upped their target price for the company from $160.00 to $175.00 in a research note on Monday, March 11th. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $170.72.
Check Out Our Latest Research Report on Procter & Gamble
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 7/1 – 7/5
- What is a Special Dividend?
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Qualcomm Stock Continues to Rise in the Face of Negative News
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.